-
“I recently incorporated SphygmoCor into my hypertension practice and I have been very pleased with the results. I have found the SphygmoCor system to be clinically valuable for total hypertension management. It provides important additional information that has already helped me make better treatment decisions for my patients."
Ricardo Cordido, MD
HeartCare Associates of Connecticut
-
“I am very glad I purchased the SphygmoCor PWA. It is of tremendous adjunctive value in clinical decision-making with regards to escalating, reducing, or continuing the same antihypertensive regimen as well as deciding whether to emphasize vasodilating agents or non-vasodilating agents. If I had my way, this would be the new gold standard for measuring clinical/office BP measurements.”
David Antecol, MD
Cardiology Associates
-
“I have been using SphygmoCor in my preventive cardiology practice for over a year, and it is an integral component of my cardiovascular risk assessment. The information derived contributes directly to the management of my patients with hypertension, as well as pre-hypertension, allowing me to quickly assess the effects of treatment and lifestyle changes."
Lee Marcus, MD, MS, FACC
Preventive Cardiology
-
“I recently implemented SphygmoCor into my nephrology practice and have found that it adds critical new information that allows me to better manage my patients’ blood pressure. I am now seeing a lot of cases where central blood pressure is far lower than I would have expected and I use this information to remove or reduce medication. When I see the patients for follow up, they feel much better and I’m finding that their creatinine levels are lower, as well. SphygmoCor has quickly become an indispensable part of our practice.”
Shahabul Arfeen, MD
Nephrology Specialists, P.C.
Health Care Professionals
SphygmoCor is the industry standard for performing central arterial pressure waveform analysis and measuring arterial stiffness, providing critical information that cannot be obtained from a brachial blood pressure measurement. This information is essential in advancing the management of hypertensive and pre-hypertensive patients as it can have a considerable impact on treatment decisions. In fact, a significant number of patients may be over-treated when only their brachial blood pressure is considered.
In the clinical management of hypertension, SphygmoCor is essential for individualizing care and better informing blood pressure management, ultimately helping physicians get patients to goal more quickly.
[st_row][st_column][st_text el_title=””]
-
“I recently incorporated SphygmoCor into my hypertension practice and I have been very pleased with the results. I have found the SphygmoCor system to be clinically valuable for total hypertension management. It provides important additional information that has already helped me make better treatment decisions for my patients."
Ricardo Cordido, MD
HeartCare Associates of Connecticut
-
“I am very glad I purchased the SphygmoCor PWA. It is of tremendous adjunctive value in clinical decision-making with regards to escalating, reducing, or continuing the same antihypertensive regimen as well as deciding whether to emphasize vasodilating agents or non-vasodilating agents. If I had my way, this would be the new gold standard for measuring clinical/office BP measurements.”
David Antecol, MD
Cardiology Associates
-
“I have been using SphygmoCor in my preventive cardiology practice for over a year, and it is an integral component of my cardiovascular risk assessment. The information derived contributes directly to the management of my patients with hypertension, as well as pre-hypertension, allowing me to quickly assess the effects of treatment and lifestyle changes."
Lee Marcus, MD, MS, FACC
Preventive Cardiology
-
“I recently implemented SphygmoCor into my nephrology practice and have found that it adds critical new information that allows me to better manage my patients’ blood pressure. I am now seeing a lot of cases where central blood pressure is far lower than I would have expected and I use this information to remove or reduce medication. When I see the patients for follow up, they feel much better and I’m finding that their creatinine levels are lower, as well. SphygmoCor has quickly become an indispensable part of our practice.”
Shahabul Arfeen, MD
Nephrology Specialists, P.C.
Health Care Professionals
SphygmoCor is the industry standard for performing central arterial pressure waveform analysis and measuring arterial stiffness, providing critical information that cannot be obtained from a brachial blood pressure measurement. This information is essential in advancing the management of hypertensive and pre-hypertensive patients as it can have a considerable impact on treatment decisions. In fact, a significant number of patients may be over-treated when only their brachial blood pressure is considered.
In the clinical management of hypertension, SphygmoCor is essential for individualizing care and better informing blood pressure management, ultimately helping physicians get patients to goal more quickly.
[/st_text][/st_column][/st_row]